{"Title": "IFN-\u03bb resolves inflammation via suppression of neutrophil infiltration and IL-1\u03b2 production", "Year": 2015, "Source": "J. Exp. Med.", "Volume": "212", "Issue": 6, "Art.No": null, "PageStart": 845, "PageEnd": 853, "CitedBy": 119, "DOI": "10.1084/jem.20140995", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84980002675&origin=inward", "Abstract": "\u00a9 2015 Blazek et al.The most studied biological role of type III interferons (IFNs) has so far been their antiviral activity, but their role in autoimmune and inflammatory diseases remains largely unexplored. Here, we show that treatment with IFN-\u03bb2/IL-28A completely halts and reverses the development of collagen-induced arthritis (CIA) and discover cellular and molecular mechanisms of IL-28A antiinflammatory function. We demonstrate that treatment with IL-28A dramatically reduces numbers of proinflammatory IL-17-producing Th17 and \u03b3\u03b4 T cells in the joints and inguinal lymph nodes, without affecting T cell proliferative responses or levels of anticollagen antibodies. IL-28A exerts its antiinflammatory effect by restricting recruitment of IL-1b-expressing neutrophils, which are important for amplification of inflammation. We identify neutrophils as cells expressing high levels of IFN-\u03bb receptor 1 (IFNLR1)-IL-28 receptor \u03b1 (IL28RA) and targeted by IL-28A. Our data highlight neutrophils as contributors to the pathogenesis of autoimmune arthritis and present IFN-\u03bbs or agonists of IFNLR1-IL28RA as putative new therapeutics for neutrophil-driven inflammation.", "AuthorKeywords": null, "IndexKeywords": ["Animals", "Arthritis", "Cattle", "CD4-Positive T-Lymphocytes", "Cell Movement", "Cell Proliferation", "Chickens", "Collagen", "Flow Cytometry", "Gene Expression Regulation", "Inflammation", "Interleukin-17", "Interleukin-1beta", "Interleukins", "Male", "Mice", "Mice, Inbred C57BL", "Mice, Inbred DBA", "Neutrophils", "Receptors, Antigen, T-Cell, gamma-delta", "Receptors, Cytokine", "T-Lymphocytes"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84980002675", "SubjectAreas": [["Immunology and Allergy", "MEDI", "2723"], ["Immunology", "IMMU", "2403"]], "AuthorData": {"36165305300": {"Name": "Blazek K.", "AuthorID": "36165305300", "AffiliationID": "60007247, 60026851", "AffiliationName": "Kennedy Institute of Rheumatology, University of Oxford"}, "55357080100": {"Name": "Eames H.L.", "AuthorID": "55357080100", "AffiliationID": "60007247, 60026851", "AffiliationName": "Kennedy Institute of Rheumatology, University of Oxford"}, "57198623233": {"Name": "Weiss M.", "AuthorID": "57198623233", "AffiliationID": "60007247, 60026851", "AffiliationName": "Kennedy Institute of Rheumatology, University of Oxford"}, "56729224600": {"Name": "Byrne A.J.", "AuthorID": "56729224600", "AffiliationID": "60007247, 60026851", "AffiliationName": "Kennedy Institute of Rheumatology, University of Oxford"}, "56724044900": {"Name": "Perocheau D.", "AuthorID": "56724044900", "AffiliationID": "60007247, 60026851", "AffiliationName": "Kennedy Institute of Rheumatology, University of Oxford"}, "7004020860": {"Name": "McCann F.", "AuthorID": "7004020860", "AffiliationID": "60007247, 60026851", "AffiliationName": "Kennedy Institute of Rheumatology, University of Oxford"}, "7409601164": {"Name": "Williams R.O.", "AuthorID": "7409601164", "AffiliationID": "60007247, 60026851", "AffiliationName": "Kennedy Institute of Rheumatology, University of Oxford"}, "7003552386": {"Name": "Udalova I.A.", "AuthorID": "7003552386", "AffiliationID": "60007247, 60026851", "AffiliationName": "Kennedy Institute of Rheumatology, University of Oxford"}, "7006480647": {"Name": "Pease J.E.", "AuthorID": "7006480647", "AffiliationID": "60010719, 60015150", "AffiliationName": "National Heart and Lung Institute, Imperial College London"}, "57190738129": {"Name": "Doyle S.", "AuthorID": "57190738129", "AffiliationID": "60013234", "AffiliationName": "ZymoGenetics, Inc."}}}